How to get export Licence for Pharma marketing? ( Diabetic products )

Healthcare and Pharmaceutical Industries in Saudi Arabia Nabil A. Issa, Esquire * Mohammad I. Al-Ammar, Esquire Salah Mostafa, Esquire King & Spalding LLP Dubai, United Arab Emirates ; and Riyadh, Saudi Arabia This article addresses the most significant S audi Arabian legal issues to be considered in connection with investment in the healthcare sector in t he Kingdom of Saudi Arabia. Saudi Arabia is the largest economy in t he Middle East and, while oil wealth has brought new opportunities, it has led to a growi ng incidence of lifestyle diseases such as diabetes and heart disease. 1 The Saudi Arabian government has established certain regulatory reforms to encourage private sector investment in the healthcare sector. This article provides an overview of the legal landscape of the Saudi Arabian healthcare sector. The first section covers the pha rmaceutical sector, and the second section covers healthcare facilities. Throughout this article, we also discuss general corporate and other issues to be considered by foreign investors in Saudi Arabia. The healthcare sector is undergoing constant change because of its high importance to Saudi Arabian nationals, and certain agencies have overlapping responsibilities, as described below. As a relevant background, one must also cons ider that Saudi Arab ian law is founded on the Shari’ah (Islamic law), largely consisting of the Holy Qur’an and the Hadith (sayings or “traditions” of the prophet Mohammed). There are four pr incipal schools of Islamic jurisprudence: Hanafi, Maliki, Hanbali and Shafi’i, each of which has its own set of